ArticleStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]2015

[TH-302: a new hypoxia-activated cytostatic agent in pancreatic cancer treatment].

Claudia Schmalz et al.PubMed ↗Publisher ↗

No numbers read from the abstract.